Pharma QC
Curia Invests $4 Million to Upgrade API Aseptic Suites in Spain to Meet New EU GMP Annex 1 Standards
Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investmen...
October 28, 2025 | News
Single Use Support Expands ISO 7 Cleanroom Capacity in Austria to Strengthen Global Biopharma Supply Chains
New ISO 7-certified facility in Austria boosts production volumes, ensures secure supply chains, and meets increasing global demand for flexible single-use...
October 28, 2025 | News
USP Launches New Solutions to Strengthen Quality Assurance for GLP-1 Receptor Agonists
The U.S. Pharmacopeia (USP) has launched a new set of solutions to support product quality for manufacturers of glucagon-like peptide-1 (GLP-1) r...
October 24, 2025 | News
AGC Biologics Partners With Rarity PBC To Advance First U.S. Commercial Gene Therapy for ADA-SCID
Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms to seek regulatory approval for a therapy treat...
October 24, 2025 | News
Building Trust Through Quality: How QMS Powers Manufacturing Excellence in Life Sciences
Life sciences sector, a robust Quality Management System (QMS) has become the cornerstone of manufacturing excellence. This is especially true for the medi...
October 16, 2025 | Analysis
Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems
Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...
October 15, 2025 | Interview
Thousand Oaks Biologics Secures EU QP Declaration for ADC Manufacturing Facility in Shanghai
Thousand Oaks Biologics' antibody-drug conjugate (ADC) manufacturing site successfully passed an audit conducted by a European Union Qualified Person ...
October 14, 2025 | News
PromoCell Enters GMP Market with Custom Cell Culture Media Services for Clinical Applications
PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into t...
October 01, 2025 | News
WuXi Biologics Launches TrueSite TI™, a Next-Generation Targeted Integration Cell Line Platform Redefining Biologics Development
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone scre...
September 29, 2025 | News
Catalent Opens New Global Headquarters in Tampa to Shape the Future of Biopharma Innovation
Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New ...
September 29, 2025 | News
Lonza and RION Partner to Scale Manufacturing of Exosome-Based Therapy PEP™
Lonza to support cGMP manufacturing of RION’s Purified Exosome Product™ (PEP™), a platelet-derived exosome-based drug candidate ...
September 24, 2025 | News
WuXi Biologics Secures First Turkish GMP Certification for Three Facilities
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...
September 18, 2025 | News
Single-Use Systems Are Rewiring Biopharma Manufacturing
Bioprocess, Unbottled Single-use systems (SUS) have become a transformative force in biopharmaceutical processing, offering an alternative to trad...
September 16, 2025 | Report
Thermo Fisher Scientific Introduces Gibco™ Efficient-Pro™ Medium (+) Insulin to Boost Titers by Up to 61% and Streamline Bioproduction
Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines Thermo Fisher Sci...
September 16, 2025 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
